<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="35018">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01738620</url>
  </required_header>
  <id_info>
    <org_study_id>QOLEC1 - step 1</org_study_id>
    <nct_id>NCT01738620</nct_id>
  </id_info>
  <brief_title>Quality of Life After Esophagectomy for Cancer - Step 1</brief_title>
  <official_title>Quality of Life After Esophagectomy for Cancer - QOLEC1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Padova</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Berlucchi Foundation, Brescia, Italy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Istituto Oncologico Veneto IRCCS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Padova</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: A recent systematic review showed that patients undergoing esophagectomy for
      cancer had scores of physical function, vitality and performance of health in general
      significantly lower than those obtained from the reference population. The analysis of the
      quality of life at six months follow-up showed that the total score and physical function
      were better before surgery and symptoms-based scales indicated that the fatigue, dyspnoea
      and diarrhea were worse six months after esophagectomy. The objective of this study is
      therefore to assess the impact of esophageal resections for cancer on the quality of life of
      patients and to improve it through simple interventions of post operative care.

      The study is divided into two steps.

      This is step 1.

      Patients will be randomized into four groups receiving respectively: psychological
      counseling for support plus appropriate measures to reduce sleep-wake rhythm disorders
      during ICU stay; psychological counseling alone; appropriate measures to reduce sleep-wake
      rhythm disorders during ICU stay alone; or standard care. The primary end point are the
      items SL (sleep disorder) and QL2 of the QLQ C30, and the secondary end point is the score
      of the PSQI.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>items SL (sleep disorder) and QL2 of the QLQ C30</measure>
    <time_frame>14 days (average time to hospital discharge)</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>PSQI score</measure>
    <time_frame>14 days (average time to hospital discharge)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">128</enrollment>
  <condition>Esophageal Cancer</condition>
  <condition>Sleep Disturbance</condition>
  <condition>Quality of Life</condition>
  <arm_group>
    <arm_group_label>psychological counseling+prevention of sleep disorders in ICU</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will receive both psychological counseling and interventions to prevent sleep disorders during their ICU stay</description>
  </arm_group>
  <arm_group>
    <arm_group_label>psychological counseling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will receive psychological counseling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>prevention of sleep disorders in ICU</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>interventions to prevent sleep disorders during their ICU stay</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>patients will receive standard care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>psychological counseling</intervention_name>
    <arm_group_label>psychological counseling+prevention of sleep disorders in ICU</arm_group_label>
    <arm_group_label>psychological counseling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>prevention of sleep disorders in ICU</intervention_name>
    <arm_group_label>psychological counseling+prevention of sleep disorders in ICU</arm_group_label>
    <arm_group_label>prevention of sleep disorders in ICU</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age above 18 years old

          -  scheduled for esophagectomy for cancer

        Exclusion Criteria:

          -  age below 18 years old

          -  incapability to autonomously fill in questionnaires

          -  primary language not italian
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlo Castoro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istituto Oncologico Veneto (IOV-IRCCS)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carlo Castoro, MD</last_name>
    <phone>049 821 1693</phone>
    <email>carlo.castoro@unipd.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Istituto Oncologico Veneto (IOV-IRCCS)</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlo Castoro, MD</last_name>
      <phone>049 821 1693</phone>
      <email>carlo.castoro@unipd.it</email>
    </contact>
    <investigator>
      <last_name>Carlo Castoro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marco Scarpa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matteo Cagol, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rita Alfieri, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lorenza Caregaro, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mariateresa Nardi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rita Marchi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Vianello, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eleonora Pinto, Psy. D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matteo Parotto, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabio Baratto, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elisabetta Saraceni, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luca M Saadeh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 5, 2014</lastchanged_date>
  <firstreceived_date>October 20, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>esophageal cancer</keyword>
  <keyword>sleep disturbance</keyword>
  <keyword>quality of life</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Esophageal Neoplasms</mesh_term>
    <mesh_term>Sleep Disorders</mesh_term>
    <mesh_term>Dyssomnias</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
